On March 17, 2025, the government published a policy paper with an Action Plan for regulation and regulators, outlining how it intends to reform ...
Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...
Seven new CERSIs came together to showcase how partnerships will modernise regulation in AI, clinical trials, and advanced therapies, bringing ...
OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today provided a regulatory update for its ...
The new test, by University College London (UCL) spinout company Sola Diagnostic, has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA). It is now available for women ...
Although the regulatory landscape for advanced therapy medicinal ... one can receive an Innovative Licensing and Access ...
A landmark study looking at all adverse drug reactions ever recorded in Britain since 1964 reveals just three genes could be ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has released updated guidance on UK-wide licensing, pharmacovigilance, labelling and packaging standards, as well as distribution ...
Medicines and Healthcare products Regulatory Agency (MHRA) for OST-HER2, its immunotherapy candidate for the prevention of recurrence of metastases in osteosarcoma. The Company released positive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback